肝胆管结石合并肝胆管癌  

Hepatolith Combined with Hepatocholangiocarcinoma

作　　者：王友顺[1] 黄宗海[1] 姜宏[1] 杨军[1] 

机构地区：[1]第一军医大学珠江医院普外科

出　　处：《中国普通外科杂志》1998年第1期29-31,共3页China Journal of General Surgery

摘　　要：对４５例肝胆管结石合并肝胆管癌的临床资料进行了回顾性分析，本组结石伴发肝胆管癌的发生率为９．７％。术前确诊率仅为６．７％。４５例中高分化腺癌占７１．１％，肿瘤位于左、右肝管者占４０％。左肝外叶占３３．３％。切除肿瘤１８例，切除率为４０％，平均生存３２．４月；姑息性内引流１１例，平均生存１１．４月；胆道外引流１１例，平均生存５．３月。结果表明：结石刺激，继发感染是肝胆管癌发病的重要因素；肝胆管癌切除预后良好，姑息性内引流术的预后明显优于外引流术。The clinical and pathological data of 45 cases of hepatocholelithiasis combined with hepatocholangiocarcinoma were retrospectively analysed. It was found that the occurrence rate of hepatocholelithiasis combined with hepatocholangiocarcinoma was 9.7%. The correct diagnosis rate of hepatocholangiocarcinoma before operation was only 6.7%. Pathological examination showed that most (71.7%) of the tumors were well differentiated adenocarcinomas. The most common location of the tumors was at the hepatic portis followed by the left lateral lobe. Eighteen patient's tumors (40%) were resected with average survival time 32.4 months; 11 patients underwent internal drainage with average survival time about 11.4 months; drain 11 patients subject to external drainage with average survival time about 5.3 months. The results suggest that hepatocholelithiasis is an important pathological factor of hepatocholangiocarcinoma. Resection of the tumor has a good prognosis; and the prognosis of internal drainage is better than that of external drainage.

关 键 词：胆管肿瘤 癌 胆结石 外科手术 治疗 

分 类 号：R735.805[医药卫生—肿瘤]